SM
PIII icon

Sciencast Management’s P3 Health Partners PIII Stock Holding History

Sciencast Management’s Portfolio PIII Stock Details PIII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-275
Closed -$105K – 611
2022
Q1 		$105K Buy
+275
New +$82.5K 0.02% 466

Other funds holding PIII

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NIP
Nicholas Investment Partners Rancho Santa Fe, California $1.39B AUM 97.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EL
EMFO LLC Weston, Florida $112M AUM 18.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SMH
Sanders Morris Harris Houston, Texas $172M AUM 22.54% 1-Year Est. Return

Sciencast Management's PIII Position: Q2 2022 in Review

Sciencast Management sold out of P3 Health Partners (PIII) in Q2 2022, closing a stake of 275 shares — an estimated $105K sold.

Sciencast Management first reported a position in PIII in Q1 2022 and held it in 1 quarter. The position peaked at $105K in Q1 2022. 47 funds tracked by Wall St. Rank hold PIII as of Q2 2022.

  • Sciencast Management reported no remaining P3 Health Partners position as of Q2 2022 after selling out during the quarter.
  • Sciencast Management sold 275 P3 Health Partners shares in Q2 2022, an estimated $105K.
  • Sciencast Management first reported a position in P3 Health Partners in Q1 2022 and held it in 1 quarter.
  • Sciencast Management's P3 Health Partners position peaked at $105K in Q1 2022.
  • 47 funds tracked by Wall St. Rank held P3 Health Partners as of Q2 2022.

Based on Sciencast Management's 13F filing for Q2 2022, filed 3 Aug 2022.